NEW YORK, NY / ACCESSWIRE / April 22, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
Diplomat Pharmacy, Inc. (DPLO)
Class Period: February 26, 2018 - February 21, 2019
Lead Plaintiff Deadline: April 25, 2019
Join the action: https://www.zlk.com/pslra-1/diplomat-pharmacy-inc-loss-form?prid=1214&wire=1
The lawsuit alleges: Diplomat Pharmacy, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants' statements about Diplomat's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Diplomat Pharmacy, Inc. class action contact email@example.com.
Conagra Brands, Inc. (CAG)
Class Period: Purchasers of common stock between June 27, 2018 and December 19, 2018, including legacy Pinnacle Foods, Inc. common stock holders who received Conagra stock in exchange for their Pinnacle shares; and shareholders who purchased shares pursuant and/or traceable to Conagra's SPO on or about October 9, 2018
Lead Plaintiff Deadline: April 23, 2019
Join the action: https://www.zlk.com/pslra-1/conagra-brands-inc-loss-form?prid=1214&wire=1
The lawsuit alleges that, during the class period, Conagra Brands, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Conagra inadequately performed proper due diligence in connection with the acquisition of Pinnacle; (ii) the performance of Pinnacle's three leading brands was not deteriorating due to intensified competition, but to self-inflicted subpar innovation and executional missteps; (iii) Pinnacle's business was performing so poorly that it had resorted to pushing promotional deals to retailers in an effort to boost sales; and (iv) as a result of the foregoing, Defendant's public statements were materially false and/or misleading and/or lacked a reasonable basis when made.
To learn more about the Conagra Brands, Inc. class action contact firstname.lastname@example.org.
CVS Health Corporation (CVS)
Class Period: May 21, 2015 - February 20, 2019
Lead Plaintiff Deadline: April 26, 2019
Join the action: https://www.zlk.com/pslra-1/cvs-health-corporation-loss-form?prid=1214&wire=1
The lawsuit alleges: CVS Health Corporation made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) CVS Health's financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with the Omnicare Acquisition; and (ii) as a result, CVS Health's public statements were materially false and misleading at all relevant times.
To learn more about the CVS Health Corporation class action contact email@example.com.
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com: